Pharmaceutical

ACU-Serve Merges With Pinnacle to Create Best-in-Class Infusion Solution

AKRON, OH / ACCESS Newswire / August 5, 2025 / ACU-Serve, a leading provider of healthcare revenue cycle and technology…

5 months ago

Los Angeles Launches Groundbreaking Mental Health Initiative for Veterans with Precise Behavioral Health Clinical Services

LOS ANGELES, CA / ACCESS Newswire / August 5, 2025 / Precise Behavioral announced today an agreement with Los Angeles…

5 months ago

Michael Jordan Game Worn Sneakers to be Auctioned by MDCE Subsidiary Infinite Auctions in “The Grail Collection” Auction

NBA Game-Worn Greatness: Bid on Rare Jerseys and Sneakers from the NBA's Most Iconic Players MESA, ARIZONA / ACCESS Newswire…

5 months ago

EnableComp Ranked #1 Specialty RCM Vendor for Complex Claims & Revenue Integrity Solutions by Hospital Financial Executives, Black Book 2025 Survey

Specialty RCM Adoption Surges as Providers Seek Automated Solutions to Rising Claim Complexity, Regulatory Pressure and Revenue Leakage NEW YORK…

5 months ago

Health Care Administrators Association (HCAA) Announces Two New Board Members

Industry experts from Goliath Sales Strategies and Marpai Rx join HCAA leadership team ST. LOUIS, MO / ACCESS Newswire /…

5 months ago

VieCure Expands Community Oncology Care Network with Addition of Summit Cancer Centers

Multi-disciplinary cancer center joins VieCure's intelligent care ecosystem, bringing advanced precision oncology capabilities to the Pacific Northwest DENVER, CO /…

5 months ago

Interactive Strength Inc. (Nasdaq: TRNR) to Release Second-Quarter 2025 Results on Thursday, August 14

AUSTIN, TEXAS / ACCESS Newswire / August 5, 2025 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or the "Company"), maker of…

5 months ago

CBD Life Sciences Inc. (CBDL) Announces National Expansion into Las Vegas Resorts & Hotels

Las Vegas CBD market projected to surpass $550 million by 2026, driven by tourism, retail, and wellness integration SCOTTSDALE, AZ…

5 months ago

HMNC Brain Health Announces Phase 2 Results from OLIVE Trial in Major Depressive Disorder (MDD) with Genetically Guided Precision Approach

BH-200 (nelivaptan) achieved clinically meaningful reduction in depressive symptoms across the full study population (Difference between BH-200 and placebo in…

5 months ago

Silo Pharma Appoints Crypto Infrastructure Pioneer Corwin Yu to Launch Institutional Bitcoin, Ethereum and Solana Treasury Platform

Targeting Multi-Chain Digital Asset Growth and Decentralized Finance (DeFi) Integration SARASOTA, FL, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Silo Pharma,…

5 months ago